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PURPOSE. Peroxisomes perform complex metabolic and catabolic functions essential for
normal growth and development. Mutations in 14 genes cause a spectrum of peroxisomal
disease in humans. Most recently, PEX11B was associated with an atypical peroxisome
biogenesis disorder (PBD) in a single individual. In this study, we identify further PEX11B
cases and delineate associated phenotypes.
METHODS. Probands from three families underwent next generation sequencing (NGS) for
diagnosis of a multisystem developmental disorder. Autozygosity mapping was conducted in
one affected sibling pair. ExomeDepth was used to identify copy number variants from NGS
data and confirmed by dosage analysis. Biochemical profiling was used to investigate the
metabolic signature of the condition.
RESULTS. All patients presented with bilateral cataract at birth but the systemic phenotype was
variable, including short stature, skeletal abnormalities, and dysmorphism—features not
described in the original case. Next generation sequencing identified biallelic loss-of-function
mutations in PEX11B as the underlying cause of disease in each case (PEX11B c.235C>T
p.(Arg79Ter) homozygous; PEX11B c.136C>T p.(Arg46Ter) homozygous; PEX11B
c.595C>T p.(Arg199Ter) heterozygous, PEX11B ex1-3 del heterozygous). Biochemical
studies identified very low plasmalogens in one patient, whilst a mildly deranged very long
chain fatty acid profile was found in another.
CONCLUSIONS. Our findings expand the phenotypic spectrum of the condition and underscore
congenital cataract as the consistent primary presenting feature. We also find that
biochemical measurements of peroxisome function may be disturbed in some cases.
Furthermore, diagnosis by NGS is proficient and may circumvent the requirement for an
invasive skin biopsy for disease identification from fibroblast cells.
Keywords: congenital cataract, PEX11B, peroxisome biogenesis disorder, genomics, next-
generation sequencing
Eukaryotic peroxisomes are single-membrane bound organ-elles harboring enzymes that operate in metabolic pathways
critical for normal human development and health and are
present in almost all cells.1 Peroxisomes show diversity and
plasticity, responding rapidly to meet the metabolic needs of
the cell.2 Amongst other roles, they are vital for the catalysis of
fatty acid a- and b-oxidation in energy metabolism,3 bile acid
production for the absorption of fat-soluble vitamins for skin
health,4 the formation of plasmalogen for the myelination nerve
cells, and for the protection of cells of the cardiovascular and
immune systems against reactive oxygen species.5
Human peroxisomal disease is caused by mutations in the
genes encoding two classes of protein: single enzyme or
metabolite transporter defects known as peroxisomal enzyme
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deficiencies (PEDs), the clinical and biochemical effects of
which are dependent on the specific function of the affected
protein; or peroxisome biogenesis disorders (PBDs) that result
from a universal abnormality of peroxisome function due to a
specific defect in one of the processes crucial for the assembly
or maintenance of peroxisomes (reviewed by Waterham et
al.6). Peroxisome biogenesis disorders are a genetically
heterogeneous group of disorders caused by biallelic mutations
in peroxin (PEX) genes. Peroxins are crucial for multiple
aspects of peroxisome biogenesis such as the maturation of
pre-peroxisomes via the import of peroxisomal membrane and
matrix proteins,7 as well as peroxisome growth, division,
fission, and proliferation.2,6,8,9 Fourteen of 16 known human
PEX genes have been linked to PBDs in humans and are known
to cause a spectrum of developmental brain disorders with a
combined estimated incidence of 1/50,000.2 Phenotypic
severity ranges from acute, multisystemic disease leading to
death in childhood as in the Zellweger syndrome spectrum
(ZSS) encompassing Zellweger syndrome, infantile refsum
disease, and neonatal adrenoleukodystrophy (reviewed by
Wanders1 and Waterham et al.6); to comparatively mild, later-
onset, or slowly progressive disorders, recently associated with
mutations in specific PEX genes.10–12
PEX11B encodes a peroxisomal membrane protein pre-
dicted to harbor two transmembrane domains and has cytosol
exposed N- and C-termini.13,14 In 2012, Ebberink et al.10
reported a homozygous nonsense mutation in PEX11B in a
single patient with a mild Zellweger spectrum phenotype of
bilateral congenital cataract, progressive deafness, polyneurop-
athy, gastrointestinal problems, and mild intellectual disability
(PBD 14B, #MIM 614920).10 Immunofluorescence staining in
patient fibroblast cells showed aberrant peroxisome quantity,
morphology, and division dynamics.10 Interestingly, all stan-
dard biochemical measurements of peroxisomal disease were
unhelpful in diagnosing this patient. Here we report three
further families with PEX11B mutations and mild biochemical
disturbances in association with a range of abnormal features
including some additional to those reported by Ebberink et
al.,10 offering further delineation of the PEX11B phenotype
and biochemical profile.
METHODS
Ethics, Patient Recruitment, and Clinical
Assessment
This research followed the tenets of the Declaration of Helsinki
and ethics committee approval was obtained from the North
West Research Ethics Committee (11/NW/0421) and the
Scottish Multicentre Research Ethics Committee (04:MRE00/
19). Written informed consent was obtained for each affected
individual as an essential pre-requisite for study inclusion.
Patients were assessed through the clinical genetics service at
their respective referral center, where they underwent full
ophthalmic, developmental, and dysmorphology examinations.
A three-generation family history and full medical history were
obtained in each case.
Molecular Investigations
Autozygosity Mapping. DNA from I.1 and I.2 underwent
Genome-Wide SNP analysis using the Affymetrix Genome-Wide
SNP6.0 microarray. Genotypes were generated using the
Birdseed V2 algorithm with a confidence threshold of 0.01,
and copy number data were generated using the SNP 6.0 CN/
LOH Algorithm both within the Affymetrix Genotyping
console. Autozygosity analysis was carried out using AutoSNPa
(http://dna.leeds.ac.uk/autosnpa/, in the public domain). Copy
number results were analyzed using the Affymetrix Chromo-
some Analysis Suite. Autozygous regions over 5 Mb that were
shared between the affected family members were used to
guide analysis of whole exome sequencing (WES) data.
Next Generation Sequencing (NGS)
Whole Exome Sequencing. Genomic DNA was extracted
from peripheral blood samples according to local protocols.
DNA libraries for whole-exome sequencing were prepared
using 3 lg of high quality DNA. Enrichment of the libraries was
conducted using Nimblegen SeqCap EZ Human Exome Library
version 3.0 (Roche Nimblegen, Madison, WI, USA) according to
manufacturer’s instructions, for the capture of the coding and
flanking intronic regions of all RefSeq RefGene CDS and
miRBase version 14 genes. Library preparations were se-
quenced on the HiSeq 2000 (Illumina, San Diego, CA, USA)
according to manufacturer’s protocols. Sequencing reads were
aligned to the GRCh37 human reference sequence with the
Burrows-Wheeler aligner (BWA version 0.6.2).15 The Genome
Analysis Tool Kit Lite (GATK version 2.0.39)16 was used for
base quality score recalibration and indel realignment prior to
variant calling using the unified genotyper (https://www.
broadinstitute.org/gatk, in the public domain).
DNA from II.1 was prepared and enriched for exonic
sequence as described above. Sequencing was carried out at
the National High-throughput DNA Sequencing Centre (Co-
penhagen, Denmark). Sequence reads were aligned to the
GRCh37 human genome reference assembly with BWA mem
0.7.10. Duplicate reads were marked with Picard MarkDupli-
cates 1.126. Reads were realigned around indels and base
quality scores recalibrated with GATK 3.3. Single nucleotide
variants and small indels were called with GATK 3.3
HaplotypeCaller on each sample and GenotypeGVCFs to
produce a raw variant call set. Variants were annotated using
the Ensembl Variant Effect Predictor.
Cataract-Targeted NGS. DNA from III.1 was enriched for
the coding regions of 115 known bilateral pediatric cataract
causing genes 6 50 bp, using an Agilent SureSelect custom
designed target-enrichment (Agilent, Santa Clara, CA, USA) as
described in Gillespie et al.,17 followed by sequencing on the
Illumina HiSeq2000 platform, according to manufacturer’s
instructions.
Copy Number Variant (CNV) Detection. Copy number
variants were detected from NGS read data using ExomeDepth
version 1.1.6.18 Copy number variants were confirmed by
dosage PCR (primer details can be found in Supplementary
Data SA). Reactions were analyzed against a GS500 ROX
standard (Applied Biosystems, Foster City, CA) and run on an
ABI 3130XL Genetic Analyzer according to manufacturer’s
instructions, using a generic Mulitplex Ligation Probe-Depen-
dent Analysis (MLPA) analysis setting.
Droplet Digital PCR (ddPCR) reactions were carried out
according to manufacturer’s instructions (Biorad, Hertford-
shire, UK). In each reaction, 50 ng of genomic DNA was
combined with a VIC-labeled TaqMan genomic control probe
(RNAseP; Life Technologies, Carlsbad, CA, USA), primers
specific for control or PEX11B loci (Supplementary Data SA),
and an appropriate FAM-labeled Universal Probe Library (UPL)
probe (Roche, Basel, Switzerland; Supplementary Data SA).
Droplets were generated using a Biorad QX200 or QX200Au-
toDG droplet generator, PCRs were carried out using a C1000
Touch Thermal Cycler, and droplets were analyzed on a QX100
Droplet Reader. The data were analyzed using Quantasoft
software (QuantaLife, Pleasanton, CA, USA).
Sanger Sequencing. Primers for PEX11B screening were
designed to amplify and sequence all coding exons plus
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intron–exon boundaries of the gene according to RefSeq
transcript NM_003846 (see Supplementary Data SA for primer
sequences) using BigDye Terminator version 3.1 Cycle
Sequencing Kit (Applied Biosystems), according to manufac-
turer’s instructions.
Biochemical Analysis. Very long chain fatty acid (VLCFA),
phytanic and pristanic acid, and/or plasmalogen enzyme
measurements in plasma from peripheral blood samples were
used to measure peroxisomal biochemical parameters in each
case.
RESULTS
Patient Phenotypes
Family I. The affected sibling pair from family I is briefly
described in Gillespie et al.19 Patient I.1 was the first born to
first cousin parents originating from Bangladesh (Fig. 1). She
had a similarly affected male cousin living in Bangladesh but no
further information was available. Born at term following an
uneventful pregnancy, she initially presented with bilateral,
dense cataracts at 6 weeks of age with associated pendular
nystagmus and divergent strabismus. She underwent surgical
treatment for the cataracts at 3 months. At that time, no other
abnormalities were detected.
At age 6.5 years, she was noted to have significant short
stature (<0.4th centile). Her occipitofrontal circumference
(OFC) was on the third centile (Table 1). She also had
prominent teeth, a high arched palate, sparse hair with a high
frontal hairline, and a lateral flare to her eyebrows. She
displayed broad, flat feet with hallux valgus and prominent
heels (Fig. 2). A skeletal survey revealed cone-shaped
epiphyses of the fingers, a fibrous cortical defect in the upper
shaft of the tibia, and a narrow thorax with sloping of the ribs,
but no unifying diagnosis could be offered on expert radiologic
review. She suffered from severe childhood eczema and mild
gastrointestinal problems, experiencing loose stools five to six
times per day. She was assessed as having mild learning
disability.
In patient I.2, bilateral cataracts (removed at 1 month of
age) and microphthalmia were observed shortly after birth. He
developed glaucoma secondary to surgery. He was generally
slow to develop (Table 1). Bilateral sensorineural hearing loss
was diagnosed at 4 years. Following this, he went on to
FIGURE 1. (A) Pedigree of Family I included in this study. Arrows indicate proband. White square or circle¼unaffected individual; black square or
circle¼ affected individual; white circle with black segment¼ individual reported to have eye problems and short stature but not formal diagnosis; *
¼ individual with eye abnormalities and/or short stature. (B) Family I shows sequencing chromatogram of PEX11B c.235C>T p.(Arg79Ter)
homozygous variant in I.1 and I.2 in comparison with control trace (arrow indicates altered nucleotide).
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develop increasing behavioral and emotional problems, be-
coming very withdrawn and uncommunicative. He had severe
gastrointestinal problems and stopped eating, necessitating a
gastrostomy at 6 years of age following which he was slow to
recover. Extreme short stature was diagnosed at 14 years for
which growth hormone treatment was ineffective. His
metacarpal and phalangeal joints were noted to be abnormal,
with proximal implanting of the thumb and he had broad, flat
feet with hallux valgus and prominent heels (Fig. 2). He is
unsteady when walking, demonstrating an unusual in-toeing
gait. He was assessed as having moderate intellectual disability.
Family II. Patient II.1, a female, was born at 38 weeks’
gestation weighing 2.3 kg (second centile) to first cousin
parents from a large, multiply consanguineous family originat-
ing from Pakistan (Fig. 3). Pregnancy was complicated by
intrauterine growth restriction (IUGR) and preeclampsia in the
third trimester. Family history revealed several affected family
members across three generations. Bilateral cataracts were
observed at birth and removed at 2 months. Subsequently, she
developed aphakic glaucoma. She was also noted to be
hypotonic, and this later evolved into four-limb spasticity.
Feeding was difficult to establish neonatally. Over the first 6
years of life, her growth parameters remained below the 0.4th
centile, and she was slow to reach developmental milestones
(Table 1). Her hearing was normal but her speech was slow to
develop and by the age of 6 years she was diagnosed with
severe intellectual disability. Neurologic assessment detected
abnormal muscle tone with reduced muscle strength but
increased tendon reflexes. Fine motor skills were present but
poor. Magnetic resonance imaging (MRI) scan at 6 years was
normal. She was noted to be prone to tantrums but had no
other behavioral problems. By the age of 13 years, she was still
unable to walk; multiple surgeries were attempted to correct
progressive talipes but were unsuccessful. Short limbs with
small hands and feet were observed. She was described as
having stubby fingers and especially short thumbs; her distal
phalanges were also abnormally short (Fig. 2). She had very dry
skin and sparse hair, which appeared normal upon microscop-
ic analysis. She developed truncal obesity and scoliosis and was
noted to be mildly dysmorphic with a large fontanelle, short
forehead, broad nasal bridge, and small mandible.
Family III. The proband from family III (III.1; Fig. 4), a
Caucasian male, was born at 38 weeks’ gestation weighing
2.353 kg (second centile), following a normal pregnancy.
Neonatal examination identified bilateral congenital cataracts
that were surgically removed (left eye at 7 weeks of age; right
eye at 9 weeks). He walked independently at 16 months, but
was delayed with his speech by 18 months, speaking fewer
than 30 words. At 20 months, his height and weight were
within normal range, though his OFC measured small (47.2 cm,
third centile). By the age of 2 years 11 months, all of his growth
parameters were below the normal range (Table 1). At 1 year of
age, he displayed jerking head movements and an electroen-
cephalogram revealed bisynchronous discharges, suggestive of
seizures, but coherence tomography (CT) and MRI scans of his
brain were normal. Urea and electrolyte measurements were
normal. He was subsequently commenced on sodium valpro-
ate. He experienced conductive hearing loss due to mild otitis
media with effusion. Behaviorally, he was described as having a
sensory disturbance that involved frequent mouthing and
licking of objects and a preference for skin-to-skin contact.
Development of fine motor skills was delayed. Dysmorphology
assessment identified a high forehead, broad nasal bridge,
epicanthic folds, upslanting palpebral fissures, and medially
sparse eyebrows.
Patient III.2 was born at 38 weeks’ gestation weighing 2.35
kg, following a normal pregnancy (Table1). Bilateral congenital
cataracts were noticed at birth and removed at 3 months ofT
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age. Clinical examination at 23 months identified developmen-
tal delay, but brain MRI was unremarkable. At 7.5 years of age,
her weight and weight measurements were on the 0.4th to 2nd
centile. She was assessed as having learning difficulties and
described as displaying impulsive behavior with no awareness
of danger, and poor concentration.
Genomic and Biochemical Analyses
Family I. Autozygosity mapping identified four shared
regions of autozygosity on chromosomes 1, 5, 17, and 19 in the
affected siblings, I.1 and I.2 (Table 2). Whole exome
sequencing data from patient I.1 was enriched for rare (minor
allele frequency [MAF] < 0.01), recessive, protein-altering
variants within these regions, leading to the identification of a
PEX11B c.277C>G p.Arg93X homozygous variant within exon
3, the penultimate coding exon of the gene, at chr1:
145,518,175 (GRCh37; Fig. 1). Sanger sequencing confirmed
the presence of this variant in her similarly affected sibling,
patient I.2. Parental samples were unavailable for testing, but
ExomeDepth dosage analysis of sequencing reads mapped to
PEX11B did not detect any large deletion or insertion events at
this locus (Supplementary Fig. S1). Standard peroxisomal
parameters in patient I.2 found blood plasma concentrations
of VLCFAs were all within normal range. He had very low
plasmalogen levels (C16 dimethyl Acetyl dimethyl acetyl
[DMA] ¼ 0.8% [normal range ¼ 3%–15%]); C18 DMA ¼ 1.5%
[normal range ¼ 3%–21%]; Table 2).
Family II. Patient II.1 was initially recruited to a Warburg
micro/Martsolf syndrome cohort (PMID: 23420520). Screening
of the entire coding region and intron/exon boundaries of
RAB3GAP1, RAB3GAP2, RAB18, and TBC1D20 did not
identify any putative pathogenic variants. Whole exome
sequencing analysis led to the identification of a homozygous
PEX11B c.136C>T p.(Arg46Ter) variant within exon 2, at
chr1: 145,517,352 (GRCh37; Table 2; Fig. 3). Screening of a
further 83 families within the Warburg micro/Martsolf syn-
drome cohort by Sanger sequencing (data not shown) and
ddPCR copy number analysis of a further 28 probands for
whom sufficient genomic DNA was available (Supplementary
Fig. S2) did not identify any additional pathogenic PEX11B
variants.
Patient II.1 was found to have normal phytanic and pristanic
acid levels. However, her VLCFA profile was mildly deranged
(C26:0¼ 0.548 [normal, range¼ 0.45–1.32], C24:0/C22:0 ratio
¼ 1.213 [elevated, normal range¼ 0.57–0.92], C26/C22:3 ratio
FIGURE 2. Abnormalities of the hands and feet of patients with PEX11B mutations. Patient I.1 (A) and patient I.2 (B) showing broad feet and hallux
vulgus; hands of patient I.2 (C) showing abnormal metacarpal and phalangeal joints and proximal implanting of the thumb; hands of patient II.1 (D)
showing abnormally short distal phalanges and proximal implanting of the thumb.
FIGURE 3. (A) Pedigree of Family II included in this study. Arrows
indicate proband. White square or circle¼unaffected individual; black
square or circle¼ affected individual; white circle with black segment
¼ individual reported to have eye problems and short stature but not
formal diagnosis; * ¼ individual with eye abnormalities and/or short
stature. (B) Family II shows chromatogram of PEX11B c.136C>T
p.(Arg46Ter) homozygous variant in II.1 that is heterozygous in his
mother (arrow indicates altered nucleotide).
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¼ 0.03 [elevated, normal range ¼ 0.003–0.02]). Interestingly,
the C24:0/C22:0 ratio score falls in to the range expected for a
Zellweger spectrum disorder (C24:0/C22:0¼0.92–2.52) unlike
previously described for PEX11B-related disease.
Family III. Patient III.1 was referred for cataract-targeted
NGS testing, which identified a c.595C>T p.(Arg199Ter)
heterozygous variant in exon 4 of PEX11B at chr1:
145,522,734 (GRCh37). Subsequent CNV analysis via Exome-
Depth version 1.1.6 indicated a ‡1.87 Kbp heterozygous
deletion of PEX11B at chr1: 145516401-145518272 (GRCh37),
encompassing exons 1 to 3 (Fig. 4). Dosage analysis was able to
confirm the presence of a deletion spanning at least exon 1 to
exon 3 PEX11B (Supplementary Fig. S3). Sanger sequencing
and dosage analysis was able to confirm the presence of both
variants in his similarly affected sibling, patient III.2. Very long
chain fatty acid analysis in both III.1 and III.2 was normal
(Table 2).
DISCUSSION
In 2012, Ebberink et al.10 described a single patient with a
complex multisystem phenotype including bilateral congenital
cataract, intellectual disability, bilateral hearing loss, gastroin-
testinal problems, and episodes of regression following trauma.
In this initial report, despite extensive metabolic investigations
for a clinically suspected mitochondrial or peroxisome defect,
a definitive diagnosis was not reached.10 A defect of
peroxisome morphology, proliferation, and division was
identified following direct microscopic analysis of cultured
patient fibroblasts. Subsequent sequencing of all genes known
to be implicated in peroxisome elongation and division led to
the identification of a PEX11B c.64C>T p.(Gln22Ter) homo-
zygous variant, assigning this novel and atypical peroxisomal
disorder to the milder end of the disease spectrum. The work
highlighted the observation that peroxisome biogenesis
defects can exist despite normal biochemical measurements
of peroxisome function; though electron microscopy of
fibroblast samples taken at a skin biopsy may show some
characteristic changes.10 However, one would normally have
to be prompted to undertake a skin biopsy for diagnosis of a
peroxisomal disorder because of abnormal biochemical results,
which are not usually present with PEX11B mutations,
suggesting direct analytical methods such as genomic analysis
FIGURE 4. (A) Pedigree of Family III included in this study. Arrows indicate proband. White square or circle¼ unaffected individual; black square
or circle ¼ affected individual; white circle with black segment ¼ individual reported to have eye problems and short stature but not formal
diagnosis; * ¼ individual with eye abnormalities and/or short stature. (B) Family III shows sequencing chromatogram indicating c.595C>T
p.(Arg299Ter) heterozygous variant in III.1 and III.2 in comparison with normal control (arrow indicates altered nucleotide). (C) ExomeDepth
analysis indicating deletion of exons 1 to 3 of PEX11B according to WES read ratios in patient III.1.
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can be the most appropriate means of diagnosis for this
heterogeneous group of disorders.
Our study provides detailed phenotypic profiles of five
additional patients from three families found to harbor biallelic
PEX11B mutations via NGS, extending the spectrum and
severity of the phenotypes associated with mutations in this
gene. In line with the phenotype described for the patient
reported by Ebberink et al.,10 all patients described in this
study cohort exhibited cataract at birth, underscoring this
abnormality as a consistent early feature of the condition.
Furthermore, this finding emphasizes the importance of
obtaining a precise diagnosis in cases of bilateral pediatric
cataract as we have previously demonstrated.17,19 Although
congenital cataract is a consistent and obvious early feature of
this condition, affected individuals appear otherwise well in
infancy. Identification of the precise genetic cause of congen-
ital cataract in infancy enables delineation of disease subtype
(i.e., distinguishes isolated cataract from cataract presenting as
a syndromic or metabolic condition), allowing the timely
implementation of a personalized approach to patient care and
importantly, disease-specific monitoring. Two of the five
patients described in this cases series developed postoperative
(aphakic) glaucoma with patient I.2 going on to develop
bilateral phthisis bulbi at 18 years of age, possibly suggesting
that patients with PEX11B mutations are at risk of developing
problems following eye surgery. Early identification of syn-
dromic forms of pediatric cataract may be used to inform risk
of surgical outcomes. Furthermore, monitoring for postoper-
ative complications and observation of the surgical outcomes
in further cases of congenital cataract due to PEX11B
mutations are indicated to provide more data of the natural
history of the eye involvement, which could inform prognosis.
Later in childhood, and further analogous to the original
PEX11B patient, all patients in this cohort were found to be
developmentally delayed and had intellectual disability. Three
of five experienced gastrointestinal abnormalities, two devel-
oped hearing loss, and three of five had dry, scaly skin that
particularly affected the hands and feet. We also report a
number of novel phenotypic features in association with
PEX11B peroxisomal disease—all patients in our cohort were
found to have short stature and three of five had sparse hair.
Two patients had subtle abnormalities of both the axial and
appendicular skeleton (patient I.1 and II.1); two were
hypotonic, whilst three of five patients were found to have
digital abnormalities with hallux-vulgus, prominent joints, or
talipes. Interestingly, two patients from different families were
found to have dysmorphic facial features reminiscent of more
severe Zellweger spectrum of disorders (ZSDs), including large
anterior fontanelle, prominent forehead, epicanthic folds,
broad nasal bridge, and high arched palate. The same two
patients were also found to be hypotonic, and one had
experienced a seizure, demonstrating further similarity with
more severe ZSDs phenotypes. An interesting observation in
II.1, given Ebberink’s description, was the occurrence of
episodic bouts of withdrawal and mutism, raising the
possibility of a specific behavioral phenotype.
The original PEX11B c.64C>T p.(Gln22Ter) homozygous
mutation was confirmed as a protein null mutation via
immunoblot analysis in fibroblast protein homogenates.20
The three PEX11B mutations identified by this study are also
predicted null genotypes via nonsense mediated decay.
However, should the transcript survive, each of these
mutations would result in truncation of the protein prior to a
C-terminal domain from amino acid 211 to 259 that is thought
to be required for homodimerization with PEX11A,21 and
interaction with PEX19 and FIS1 for normal peroxisome
membrane proliferation and trafficking.14,22 Nonetheless, in
each case, the residual peroxisomes are partially functionalT
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given the near normal VLCFA results in the probands,20
suggesting redundancy of the gene product. PEX11 (PEX11A,
PEX11B, and PEX11G) proteins are known to have an
important role in the elongation and constriction of peroxi-
somes, and PEX11B is known to function in the growth and
division pathway of peroxisome biogenesis and specifically in
the elongation and constriction of peroxisomes, prior to fission
of organelles, orchestrated by DLP1 and FIS1.23,24 Ebberink et
al.10 found that when PEX11B deficient fibroblasts were
cultured at a high temperature, they lost their ability to import
catalase and were slow to recover from this stress, potentially
mimicking the slow recovery phenotypes of patients with
PEX11B–related disease.6,10
In summary, this study describes a further five individuals
from three families with PBD 14B attributable to novel biallelic
loss of function mutations in PEX11B. We describe additional
phenotypic features to those reported in the first and only
description of this disorder,10 thereby expanding the pheno-
typic spectrum of the disease. Importantly, our findings
underscore congenital cataract, the primary presenting feature
of the condition, and highlight the importance of determining
the precise molecular cause of bilateral cataract in neonates. It
is also worth noting the tentative clinical diagnosis of Warburg
micro/Martsolf syndrome that was made in one of our cases,
suggesting that PEX11B should be considered in such cases
that are mutation negative for RAB3GAP1/2, RAB18, and
TBC1D20. Our work adds to cumulative evidence that NGS
technologies offer a proficient means of diagnosis of this group
of genetically heterogeneous and phenotypically variable
group of disorders,25–27 especially since PEX11B-related
disease escapes detection using standard peroxisomal bio-
chemical measurements. In addition, direct gene analysis
through this route avoids the need for diagnosis by invasive
skin biopsy, which is not acceptable to all patients.
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